OFFICIAL LEGAL TITLE
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_HR_7679.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2022-05-06.
What are the main provisions?
Key points include:
- Extends the ability to grant exemptions for medical devices for small patient populations until 2027, encouraging their development.
- Extends the program supporting the development of pediatric medical devices until 2027, potentially leading to better solutions for the youngest patients.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Fletcher, Lizzie [D-TX-7].
What is the latest detailed status?
The latest detailed status is: Referred to the House Committee on Energy and Commerce.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.